|
|||||
|
|
Epoetin alfa: patient management issues and development through recombinant DNA technology. Part 2: Answers to questions about Epoetin alfa |
|
| Authors: | N Gallagher D Latham B Prowant L Binkley R Chapin L Erlich E Nichols D Osborne |
| Abstract: | |
| Keywords: | |